All lobbying filings

CAPITOLINE CONSULTING, LLC

CAPITOLINE CONSULTING, LLC filed a Q4 report for EVONIK CORPORATION on January 17, 2026, reporting $50,000 in lobbying income.

Lobbying for EVONIK CORPORATION · Specialty chemicals company

All filings by CAPITOLINE CONSULTING, LLC · Everything EVONIK CORPORATION has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 17, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

New Jersey

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 7

Chemicals/Chemical Industry

Issues related to TSCA reform Issues related to EPA Premanufacturing Notices Issues related to new chemical reviews PFAS/PFOA oversight and regulatory efforts

Environment/Superfund

Oversight of EPA rules and regulations S.623 / H.R.1415 - No IRIS Act Make American Healthy Again (MAHA) GRAS issue

Tariff (miscellaneous tariff bills)

Issues related to the Administrations tariff actions and related Congressional oversight

Budget/Appropriations

FY26 appropriations actions H.R. 5371/ P.L. 119-37 FY2026 Continuing Appropriations, Agriculture, Leg. Branch & Extensions Act

Trade (domestic/foreign)

U.S./China ongoing trade issues Issues related to various trade agreement discussions USMCA Review Process

Taxation/Internal Revenue Code

General issues related to corporate tax

Railroads

Issues related to the Surface Transportation Board (STB) and rail mergers

Bills named in this filing 3

S. 623
No IRIS Act of 2025
H.R. 1415
No IRIS Act of 2025
H.R. 5371
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions …

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.